Evidence map›Paper›PMID 36323494›Full record

ArticleAndrology2023

Combined plasma levels of IL-10 and testosterone, but not soluble HLA-G5, predict the risk of death in COVID-19 patients.

Giada Amodio, Paolo Capogrosso, Marina Pontillo, Michela Tassara, Luca Boeri, Cristina Carenzi, Daniele Cignoli, Anna Maria Ferrara, Giuseppe A Ramirez, Cristina Tresoldi and 12 more

Open access · hybridAbstract read
In one paragraph

Article in Andrology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Association ofDiseases (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 1 country.

Giada AmodioSan Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS Ospedale San Raffaele, Milan, Italy.ORCID 0000-0002-2457-387X
Paolo CapogrossoDivision of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.ORCID 0000-0003-2347-9504
Marina PontilloLaboratory Medicine Service, IRCCS Ospedale San Raffaele, Milan, Italy.
Michela TassaraLaboratory Medicine Service, IRCCS Ospedale San Raffaele, Milan, Italy.
Luca BoeriDivision of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.ORCID 0000-0003-0040-784X
Cristina CarenziDivision of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
Daniele CignoliDivision of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.ORCID 0000-0001-7873-7318
Anna Maria FerraraDivision of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
Giuseppe A RamirezUniversity Vita-Salute San Raffaele, Milan, Italy.
Cristina TresoldiMolecular Hematology Unit, IRCCS Ospedale San Raffaele, Milan, Italy.
Massimo LocatelliLaboratory Medicine Service, IRCCS Ospedale San Raffaele, Milan, Italy.
Luca SantoleriImmunohematology and Transfusion Medicine, IRRCS Ospedale San Raffaele, Milan, Italy.
Antonella CastagnaUniversity Vita-Salute San Raffaele, Milan, Italy.ORCID 0000-0002-8338-9714
Alberto ZangrilloUniversity Vita-Salute San Raffaele, Milan, Italy.ORCID 0000-0002-7687-7648
Francesco De CobelliUniversity Vita-Salute San Raffaele, Milan, Italy.
Moreno TresoldiGeneral Medicine and Advanced Care Unit, IRCCS Ospedale San Raffaele, Milan, Italy.ORCID 0000-0003-1541-6650
Giovanni LandoniUniversity Vita-Salute San Raffaele, Milan, Italy.ORCID 0000-0002-8594-5980
Patrizia Rovere-QueriniUniversity Vita-Salute San Raffaele, Milan, Italy.
Fabio CiceriUniversity Vita-Salute San Raffaele, Milan, Italy.ORCID 0000-0003-0873-0123
Francesco MontorsiDivision of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
Andrea SaloniaDivision of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.ORCID 0000-0002-0595-7165
Silvia GregoriSan Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS Ospedale San Raffaele, Milan, Italy.ORCID 0000-0002-3517-9683
IRCCS Ospedale San Raffaele · ITVita-Salute San Raffaele University · ITOspedale di Circolo e Fondazione Macchi · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe identification of biomarkers correlated with coronavirus disease 2019 (COVID-19) outcomes is a relevant need for clinical management. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is characterized by elevated interleukin (IL)-6, IL-10, HLA-G, and impaired testosterone production.

objectivesWe aimed at defining the combined impact of sex hormones, interleukin-10, and HLA-G on COVID-19 pathophysiology and their relationship in male patients. MATERIALS AND

methodsWe measured by chemiluminescence immunoassay, electrochemiluminescent assays, and enzyme-linked immunosorbent assay circulating total testosterone, 17β-estradiol (E RESULTS AND DISCUSSION: We found significantly higher levels of IL-10, HLA-G, and E

conclusionOur findings indicate that combined evaluation of IL-10 and testosterone predicts the risk of death in men with COVID-19 and support the hypothesis that IL-10 fails to suppress excessive inflammation by promoting viral spreading.

Indexed as

COVID-19HLA-G AntigensHumansImmunoglobulin GInterleukin-10Interleukin-6MaleSARS-CoV-2TestosteroneHLA-G AntigensImmunoglobulin GInterleukin-10Interleukin-6TestosteroneCOVID-19HLA-GIL-10maleSARS-CoV-2testosterone

Identifiers

PMID36323494
PMCPMC9877736
OpenAlexW4308056789

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.